Detalhe da pesquisa
1.
Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate.
Proc Natl Acad Sci U S A
; 119(11): e2112008119, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263223
2.
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.
Proc Natl Acad Sci U S A
; 118(3)2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431677
3.
An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development.
Gastroenterology
; 162(2): 562-574, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34655573
4.
Hepatitis E virus seropositivity in an ethnically diverse community blood donor population.
Vox Sang
; 118(8): 674-680, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366233
5.
Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization.
J Virol
; 94(22)2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878891
6.
Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design.
PLoS Pathog
; 15(5): e1007772, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31100098
7.
Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells.
J Virol
; 93(7)2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651366
8.
Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection.
Hepatology
; 70(5): 1506-1520, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31062385
9.
Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.
Proc Natl Acad Sci U S A
; 113(45): E6946-E6954, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27791171
10.
Apolipoprotein E Mediates Evasion From Hepatitis C Virus Neutralizing Antibodies.
Gastroenterology
; 150(1): 206-217.e4, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26404951
11.
Antibody Response to Hypervariable Region 1 Interferes with Broadly Neutralizing Antibodies to Hepatitis C Virus.
J Virol
; 90(6): 3112-22, 2016 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26739044
12.
Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
J Virol
; 90(1): 279-91, 2016 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26468532
13.
Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.
Hepatology
; 64(6): 1881-1892, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351277
14.
Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in mice.
Hepatology
; 64(6): 1922-1933, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641232
15.
Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody.
J Biol Chem
; 290(16): 10117-25, 2015 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25737449
16.
Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.
J Virol
; 89(4): 2170-81, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25473061
17.
Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423.
PLoS Pathog
; 10(8): e1004297, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25122476
18.
Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape.
PLoS Pathog
; 9(5): e1003364, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23696737
19.
Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a.
Hepatology
; 60(5): 1551-62, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043937
20.
Learning from a clinical cohort for HCV vaccine development.
J Hepatol
; 71(1): 9-11, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30992137